Clinical trial Recruiting at 1 site Observational Ages 2 and up

Observational study of kidney disease patients in China

Official title: China Kidney Patient Trials Network

Run by Emerald Clinical Inc. · NCT05036850 · Data updated 2026-11-12

This study is trying to learn more about how kidney diseases progress and are managed by following patients in China who have been diagnosed with these conditions.

Quick facts

Study typeObservational
Ages2 Years and up
SexAll
Enrollment1200 (estimated)
SponsorEmerald Clinical Inc.
Industry-sponsored
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedSeptember 27, 2021
Main results expectedSeptember 15, 2026
Study endsFebruary 28, 2031
Registry record updatedMarch 6, 2023
Trial IDNCT05036850 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals aged 2 years and older with a documented diagnosis of primary kidney disease and an eGFR greater than 15 ml/min/1.73 m2.

Probably not a fit

Patients with a life expectancy of less than 6 months will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational cohort study aims to gather data on both new and existing patients diagnosed with various kidney diseases in China. It will involve regular follow-ups with participants who meet specific eligibility criteria, including a documented diagnosis and a minimum eGFR level. The study seeks to understand the progression and management of kidney diseases, contributing valuable insights to the field. By collecting comprehensive data, the study hopes to inform future interventional research.

Why it matters

Potential benefit: If successful, this study could enhance understanding of kidney disease progression and improve patient management strategies.

How similar studies have gone: While observational studies on kidney diseases are common, the specific approach and focus of this study may provide novel insights into patient management.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Documented diagnosis of primary kidney disease
2. Regular visits (at least 6 monthly) with a physician at a participating site
3. eGFR \> 15 ml/min/1.73 m2
4. ≥ 2 years of age
5. Willing and able to sign informed consent
6. Willing to be approached about participation in interventional research studies

Exclusion Criteria:

* 1\. Life-expectancy of less than 6 months

Where it's running

  • George Clinical (Beijing)
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.